Finanzwire Finanzwire
Basculer en Français
9982 Companies
202335 Keywords
132958 Articles
107443 Press releases
Headlines Articles Press releases THERAVET Remove
  1. Home
  2. Companies
  3. THERAVET
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/07/2025 at 20:02, 11 months 28 days ago

    EGEIRO Pharma declares bankruptcy after decision of the Board of Directors

    Bankruptcy TheraVet Reverse Acquisition EGEIRO Pharma Suspension Of Actions
  • BRIEF

    published on 09/30/2024 at 07:35, 1 year 5 months ago

    TheraVet Announces Strategic Shift to Idiopathic Pulmonary Fibrosis

    Restructuring Phase II TheraVet H4Orphan Pulmonary Fibrosis
  • PRESS RELEASE

    published on 09/30/2024 at 07:30, 1 year 5 months ago

    Inside Information / Operations of the issuer (acquisitions, sales...)

    TheraVet and H4Orphan collaborate on a strategic project to create a leader in idiopathic pulmonary fibrosis, focusing on innovative treatments. Shareholders to vote on Operation in October 2024
    Shareholders Vote Strategic Project TheraVet H4Orphan Idiopathic Pulmonary Fibrosis
    Logo of THERAVET
  • PRESS RELEASE

    published on 09/12/2024 at 07:30, 1 year 5 months ago

    Inside Information / Other news releases

    TheraVet announces 2024 half-year results with positive sales growth and reduced operating loss. Company focuses on refinancing options and operational milestones
    Sales Growth Refinancing Operating Loss 2024 Half-year Results TheraVet
    Logo of THERAVET
Accesswire
  • Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago

    EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada

  • Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago

    GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report

  • Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago

    Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters

  • Published on 03/05/2026 at 13:40, 2 hours 5 minutes ago

    Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

  • Published on 03/05/2026 at 13:30, 2 hours 15 minutes ago

    Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend

View all ACCESSWIRE
EQS Group
  • Published on 03/05/2026 at 15:32, 13 minutes ago

    Correction of a release from 31.12.2025 07:30 GMT/BST - Restoration- daVictus Plc

  • Published on 03/05/2026 at 15:07, 38 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

  • Published on 03/05/2026 at 15:07, 38 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Senior plc

  • Published on 03/05/2026 at 15:06, 39 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

  • Published on 03/05/2026 at 15:05, 40 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: JTC plc

View all EQS
Les Echos
  • Published on 03/05/2026 at 13:20, 2 hours 25 minutes ago

    Voting rights

  • Published on 03/05/2026 at 07:30, 8 hours 15 minutes ago

    Share buyback finalized

  • Published on 03/04/2026 at 23:50, 15 hours 55 minutes ago

    Total number of voting rights and shares making up the share capital at February 28, 2026

  • Published on 03/04/2026 at 18:00, 21 hours 45 minutes ago

    Disclosure of Share Capital and Voting Rights as of February 28, 2026

  • Published on 03/04/2026 at 17:45, 22 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy